chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a non-contactable pharmacist. A pharmacist reported a patient of unspecifed age and gender received PREVNAR 13 on an unspecified date at single dose for immunization. The patient had a big tattoo so the vaccination was given in higher than normally to avoid the tattoo however the patient had swelling at the site of injection. The vaccination might be administered in the different muscle and not deltoid muscle and might have hit the pectoral muscle of shoulder. The outcome of the events were unknown. No follow-up attempts are possible. No further information is expected.
Initial report was received from a consumer on 24 October 2012. This case involved a cluster of four unidentified patients who experienced adverse events following FLUZONE, lot number UH721AB. Four unidentified patients had received intramuscular injections of FLUZONE, lot number UH721AB, within the last month and had reactions. They all got sick like the flu. One patient was hospitalized and diagnosed with toxic encephalopathy. The patients' outcomes were unknown. Documents held by sender: None.
Patient felt unwell and had to sit.  Felt extremely dizzy and hot/cold (alternating).  Patient was sweating profusely and very drowsy.  Recovered after sitting and drinking Peidalyte.  Patient is still having tingling in limbs the day after the vaccine.
2 minute seizure (tonic-clonic) with neg. CT/labs, or any other reasons for seizure, self resolving.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 25-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
9/29/21 pt admitted to hospital with osteomyelitis; has been receiving out patient IV ABX; diarrhea and fever; dx with positive COVID test on 10/5/21;  worsening respiratory status requiring intubation; AHRF; transferred to ICU; condition still worsened with acute renal failure in the setting of CKD; developed UTI - given ABX; developed fever; refractory shock and expired in the hospital
Fever and vomiting approximately 30 hours after receiving vaccine. Also with headache. Symptoms improving today 1/10/2023.
I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 1/5/2022 DM 2 W EYE MANIFESTATION I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 1/5/2022 PALLIATIVE CARE I21.09 ACUTE ST ELEVATION MI, ANTERIOR WALL 1/5/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Patient became hypotensive and bradycardic in the 40s. Patient passed out 4 times.  EMS called over.  Patient refused IV or further medical treatment.  30 min with EMS. Then observed for an additional 30 mins in the observation area of the POD.
Swelling, redness, tenderness lasted 2 days. TX Benadryl.
09/20/2012 received pediatric dose of 0.25 ml, not the recommended 0.5ml dose.  On October 4, 21012 child received an additional 0.25 ml dose of the vaccine.  Parent states the child was seen by her pediatrician the next day for a stomachache. No other symptoms. On 10/06/12 parent reports her daughter is well and has no symptoms.
Pain and swelling at the injection site; headache; dizziness; "head fog"; tiredness; muscle twitches; face numbness/tingles; chest tight; heart palpitations;
mom reports pt broke out 1APR99 & area below lt scapular approx area 4x3-2 areas approx size of nickle looked like several blisters in a circle w/other small red bumps;area itched severely, no pain;herpes zoster;
I did not allergy to any thing even eggs and after injection of flu shot start swelling all my body, angioedema, my face, both eyes, even once I could not able to breath. Up to now I visited by five providers, one of them was immunologist, and still I have symptoms and not recovered yet.
Approximately 5 minutes following his vaccine, patient began signs of fainting or possible seizure activity due to rigid body, slurred speech, neck stiffening, tingling in fingers, nausea. this lasted approximately 10 minutes. 911 was immediately called. Patient was accessed and had a heart rate of 50 and a blood pressure of 96. It was recommended that he go to the hospital for an evaluation.
patient was to receive the pediatric covid vaccine, but the adult dose vial was selected and mixed/administered according to the pediatric directions (1.3ml diluent and 0.2ml dose). mom reports soreness in the arm, but no other side-effects at this time.
Patient reports breaking out in hives a few hours after receiving the Engerix-B vaccine.  Additionally, she reported that her lips began to swell.  She self-treated with OTC diphenhydramine which alleviate oral symptoms.  But with persisting rash and hives, she presented to the ED and was subsequently treated with oral corticosteroids and antihistamines.
His daughter was in so much pain she couldn't walk to school; His daughter was in so much pain she couldn't walk to school; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (His daughter was in so much pain she couldn't walk to school) and MOVEMENT DISORDER (His daughter was in so much pain she couldn't walk to school) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (His daughter was in so much pain she couldn't walk to school) and MOVEMENT DISORDER (His daughter was in so much pain she couldn't walk to school). At the time of the report, PAIN (His daughter was in so much pain she couldn't walk to school) and MOVEMENT DISORDER (His daughter was in so much pain she couldn't walk to school) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. No treatment information was provided.   This case was linked to MOD-2021-060448 (Patient Link).
Severe headaches, fever, chills, cold/flu like symptoms, body pain, back pain, sleepless, sore at sight of injection, blood in coughed up phlegm.
1FEB93 pt devel swelling in the joints of fingers, arthralgia, itching in legs, fatigue, loss of memory, lack of ability to concentrate, rash w/spots on hands, one pupil was not able to fully dilate & loss of vision;dizziness;balance off;
Acute appendicitis and associated gram negative (E. coli) sepsis which occurred within 24 hours after administration of her second Pfizer COVID-19 vaccination
Both doses hurt like hell, the shot hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR025388  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient got both Shingles shots and he/she mentioned that it hurted like heck, but rather had the shot hurt then to had shingles. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR025388:Same reporter.
Vaccine was initially stored in refrigerator (lot number: AS7173B) on 06-Mar-2023 and vaccine was administered on 14-Apr-2023.; No adverse event; Patient received vaccine that was stored in the refrigerator 7 days past 30-day storage mark; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was stored in the refrigerator 7 days past 30-day storage mark), PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator (lot number: AS7173B) on 06-Mar-2023 and vaccine was administered on 14-Apr-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Apr-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was stored in the refrigerator 7 days past 30-day storage mark). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator (lot number: AS7173B) on 06-Mar-2023 and vaccine was administered on 14-Apr-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was stored in the refrigerator 7 days past 30-day storage mark), PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator (lot number: AS7173B) on 06-Mar-2023 and vaccine was administered on 14-Apr-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was stored in the refrigerator 7 days past 30-day storage mark) and PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator (lot number: AS7173B) on 06-Mar-2023 and vaccine was administered on 14-Apr-2023.).    No concomitant medications were provided. Dosage text reported as unknown. The vial was initially stored in the refrigerator on 06-Mar-2023. The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 9th of 10 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-728204 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-728204:Master case  Patient no-1
It began at eight PM 23FEB2023 with a sore throat, the next morning the sore throat continued and I also noted a fever, in the evening around five PM  I noted my heart rate was120BPM for several hours at that point I scheduled a telehealth appointment and after describing my symptoms to the provider it was recommended to monitor and stay hydrated the following day 25FEB2023 all major symptoms self revolved.
Day after my second vaccine I had body aches, muscle and joint aches, neck stiffness, headaches and was nauseated. I hurt so bad that I did not want to move. I Routinely took Ibeprofen every 6 hours and phenergran to help with my symptoms. These symptoms only last one day. Which was the day after my second vaccine.
Moderna Vaccine EUA. Rash that was itchy, painful to touch, warm and swollen began at the injection site. It expanded over 24 hours to 10 cm in diameter. Benadryl did not help. Out of concern for cellulitis, oral Doxycycline was prescribed and rash faded over 1 week. Mild residual tenderness to touch remains at the site but no apparent rash. Second dose received 1/25/2021 at same pharmacy  (lot 028L20A). Similar, but as yet smaller reaction at injection site is occurring, starting on the third day. Injection this time was in other(left) arm.
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Mild, Additional Details: A few minutes after receiving the vaccine the patient passed out in the waiting area chair.  EMS was immediately called. She was in and out for several minutes and vomited a bit before the fire department arrived.  She was treated on site and released to go home.
I received the above RSV vaccine 09/24 and had no immediate issues. I awoke this morning with low grade fever and myalgias. Temp of 1 degree above normal . No specific symptoms other than myalgias. no cough , sore throat bad headache. If I stilll have fever in am I will check a COVID swab. I have had COVID x 2 . I am better as the day has progresses. No Rash , no bleeding , only mild soreness at the injection site. I have not had major reaction to prior vaccine other than Low grade fever after my second COVID booster. I intend to get the Influenza vaccine in October as well as the COVID booster.
vomiting, nausea, headache, muscle pain, chills, sweats, fatigue, pain, tenderness, swelling redness, dizziness. 90 hours later still have redness, pain, tenderness and swelling at injection site and surrounding the site.
This spontaneous report as received from a physician (internal medicine specialist), via a company representative, refers to an 85 year old female patient. No information on medical history, concurrent conditions or concomitant drugs was provided. On an unspecified date in April 2010 the patient was vaccinated with ZOSTAVAX, single 0.65 ml shot, subcutaneously. On an unknown date in April 2010 after receiving a dose of ZOSTAVAX the patient developed pain on one side and a rash. On 07-APR-2014 the patient was diagnosed with shingles. The patient sought medical attention via visiting a physician and received not further specified "antiviral antibiotic" (dosage, frequency, manufacturer unknown) as a treatment. The outcome of the reported adverse events was assessed as recovering/resolving by the reporter. Relatedness between vaccination with ZOSTAVAX and adverse events was not reported. Additional information has been requested.
Stomach pain; Diarrhea; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included spina bifida and scoliosis. The patient previously had fruits and experienced fruit allergy. Concomitant medications taken within two weeks prior to the vaccination included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) for birth control and fluticasone propionate (FLONASE) for unknown indication, both from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 19:00, the patient experienced stomach pain, diarrhea, nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events stomach pain, diarrhea, nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pain at injection site (similar to first vaccine); This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 31Mar2021 15:45 (Lot number: ER8734) at the age of 27 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MIRENA. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "not recovered", described as "Pain at injection site (similar to first vaccine)". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Facility type vaccine was Pharmacy or Drug Store. No other vaccine in four weeks. Other medications in two weeks was Mirena IUD, Women's Multi. No covid prior vaccination. Not tested for COVID post vaccination. There were no known allergies.   No follow-up attempts are possible. No further information is expected.
p/vax pt devel inconsolable, high pitched crying that lasted @ least 3hr;
Woke up with heart racing/pounding on 04/05/2021, went to ER where blood pressure was 193/110, heart rate 108, given IV meds-metoprolol and discharged with instructions to see PCP and cardiologist. Patient states he saw Dr. who said he "didn't know what to do", sent to cardiologist who put patient back on metoprolol 12.5mg. Patient reports he continues to have extreme fatigue with minimal exertion.
Left fifth digit numbness and tingling started 1.5hours after administration and has not resolved x2 weeks post administration. Dr. seen on 10/8/21 and reported numbness on ulnar side of wrist and 5th finger, part of palmar surface healed, and now 1/2 of 4th finger involved. Provider will follow up in 1 week.
fever 103.2 degrees w/in 4 hrs of shot; fever @ 102 @ 2 days later; no swelling or redness @ site; no react to prev shots;
Headache, Myalgia, Arthralgia, Fever, ARM PAIN, CHILLS Narrative:
Patient called and said she was having severe body aches and nausea. She said she woke up with it the following morning after receiving Moderna. I asked her if she was warned that those were possible side affect and she said yes but she didn't think they would be that severe.
Shots given in left arm - swelling, redness, itching at site of yellow fever shot that remains today. Left leg hurt - burned for around 1 hour ( woke me up in night ). Severe migraine with nonstop naseau and vomiting until given a shot of phenergan, demerol by physician (5-6 hrs) during am.
This case was reported by a physician via call center representative and described the occurrence of pain in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain, fever, influenza-like symptoms and feeling bad. On an unknown date, the outcome of the pain, fever, influenza-like symptoms and feeling bad were unknown. It was unknown if the reporter considered the pain, fever, influenza-like symptoms and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The physician reported patients that received SHINGRIX experienced symptoms after. The patient experienced adverse event after receiving 2 doses of SHINGRIX vaccine. The reporter was reluctant to provide data on 3 patients. The follow up would be requested, if safety contacted the reporter. Till the time of reporting no other information was provided. This case was 1 of 3 cases, reported by same reporter.
Bells Palsy and Facial swelling in right side of face. Noticed a few days after receiving my first dose of the vaccine.  Still experiencing symptoms and waiting to see a neurologist but hoping for a clear course of treatment
p/vax pt devel fever & seizures; loss of eye contact; stopped communicating; less responsive; Dx: c/autism; Dx nl a/vax  Doc  195663 states the following: lack of communication, seizures, eye contact laching occurred. Possible additional problem occurred when chicken pox shot was administered on 04/22/1998. No MMR fooster given per pediatrician's recommandation that could cause further damage.
Patient was mistakenly administered 0.25ml of air initially before actually getting 0.25ml of moderna vaccine in different site but in same right arm. Patient's doctor was informed about the incident. Patient left pharmacy after about 15 minutes of administration without signs of reaction.
No adverse event; A Bivalent booster vaccination that was 6 days past use date. The use by date was 4/8/2023. The vaccine was administered 4/13/2023.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A Bivalent booster vaccination that was 6 days past use date. The use by date was 4/8/2023. The vaccine was administered 4/13/2023.) and NO ADVERSE EVENT (No adverse event) in a 20-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 066H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Apr-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (A Bivalent booster vaccination that was 6 days past use date. The use by date was 4/8/2023. The vaccine was administered 4/13/2023.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A Bivalent booster vaccination that was 6 days past use date. The use by date was 4/8/2023. The vaccine was administered 4/13/2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A Bivalent booster vaccination that was 6 days past use date. The use by date was 4/8/2023. The vaccine was administered 4/13/2023.).    Concomitant medications were not reported.  It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Reporter stated that her facility administered a Bivalent booster vaccination that was 6 days past use date. The use by date was 08-Apr-2023. The vaccine was administered 13-Apr-2023. No report from patient and no reported symptoms.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-719718 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2023: Live follow up received. Updated patient details, event verbatim and narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-719718:1st adult patient